These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 7093485)
21. [Functional and structural vascular reactions following intermittent administration of angiotensin in spontaneously hypertensive rats]. Matthias D; Schmidt R; Engler E; Becker CH Biomed Biochim Acta; 1983; 42(2-3):215-23. PubMed ID: 6882408 [TBL] [Abstract][Full Text] [Related]
22. Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat. Lee JY; Buckner SA; Brune ME; Warner RB; Winn M; De B; Zydowsky TM; Opgenorth TJ; Kerkman DJ; Debernardis JF J Pharmacol Exp Ther; 1994 Jan; 268(1):427-33. PubMed ID: 8301584 [TBL] [Abstract][Full Text] [Related]
23. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin. Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894 [TBL] [Abstract][Full Text] [Related]
24. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863 [TBL] [Abstract][Full Text] [Related]
25. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats. Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815 [TBL] [Abstract][Full Text] [Related]
26. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. Kost CK; Herzer WA; Li P; Jackson EK J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular reactivity to noradrenaline and angiotensin in normotensive, hypertensive and 6-hydroxydopamine treated rats. Anokbonggo WW West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):1-8. PubMed ID: 1023507 [TBL] [Abstract][Full Text] [Related]
28. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Wang DS; Xie HH; Shen FM; Cai GJ; Su DF Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors. Ognibene DT; Oliveira PR; Marins de Carvalho LC; Costa CA; Espinoza LA; Criddle DN; Tano T; Soares de Moura R; Resende AC Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):12-9. PubMed ID: 18986337 [TBL] [Abstract][Full Text] [Related]
30. Pressor responsiveness to angiotensin in renovascular and steroid hypertension. Marks ES; Thurston H; Bing RF; Swales JD Clin Sci (Lond); 1979 Dec; 57 Suppl 5():47s-50s. PubMed ID: 396091 [TBL] [Abstract][Full Text] [Related]
31. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats. Shin HS; Seo HW; Oh JH; Lee BH Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113 [TBL] [Abstract][Full Text] [Related]
32. The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonist. Benetos A; Gavras H; Stewart JM; Vavrek R; Hatinoglou S; Gavras I Agents Actions Suppl; 1987; 22():355-64. PubMed ID: 2829598 [TBL] [Abstract][Full Text] [Related]
36. [Effect of neonatal sympathectomy on systemic hemodynamics and myocardial contractility in spontaneously hypertensive rats]. Markov KhM; Kozlov AV; Pinelis VG; Vakulina TP Biull Eksp Biol Med; 1983 Oct; 96(10):35-7. PubMed ID: 6626727 [TBL] [Abstract][Full Text] [Related]
37. [On the vasopressor effect and inactivation of angiotensin in essential and renal as well as experimental hypertension]. Wernze H; Hosoda S; Schölkens B Arch Klin Med; 1968; 214(3):286-305. PubMed ID: 4300861 [No Abstract] [Full Text] [Related]
38. [Recent knowledge in the pathophysiology, pathogenesis and hemodynamics of arterial hypertension as a base for scientifically founded diagnosis and therapy]. Wedler B Z Arztl Fortbild (Jena); 1984; 78(24):1011-8. PubMed ID: 6528646 [No Abstract] [Full Text] [Related]
39. [Experimental study of the antihypertensive activity of unithiol, D-penicillamine and cysteine]. Mashkovskiĭ MD; Shvarts GIa Farmakol Toksikol; 1983; 46(6):24-8. PubMed ID: 6653753 [TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the renin angiotensin mechanism in experimental renovascular, human and essential hypertension. Usefullness of the analogs]. Taquini AC Arch Inst Cardiol Mex; 1977; 47(3):357-64. PubMed ID: 921391 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]